Search results
(1 - 2 of 2)
- Title
- A Randomized Controlled Trial of Direct-to-Consumer Advertising of Cognitive-Behavior Therapy for Depression
- Creator
- Antler, Caroline
- Date
- 2020
- Description
-
Almost half of individuals in the US struggling with depression never seek treatment and, of those that do, over half receive inadequate care....
Show moreAlmost half of individuals in the US struggling with depression never seek treatment and, of those that do, over half receive inadequate care. Although the efficacy of CBT for MDD is well established, the rate of individuals receiving psychotherapy has declined. With copious evidence supporting the effectiveness of direct-to-consumer advertising (DTCA) of pharmaceuticals, the current study evaluated the potential utility of DTCA of CBT for MDD.One hundred seventy-eight adults with (a) prior exposure to DTCA for antidepressants and (b) no mental health diagnoses or treatment were randomly assigned to view one of three video conditions: CBT for depression (CBT, n = 60), CBT plus information on antidepressants (CBT+MED, n = 58), or Control (arthritis and diabetes Public Service Announcements (PSAs); n = 60). After viewing the video participants completed measures of attitudes about, and willingness to engage in, CBT and antidepressant medication. The study was conducted online with participants being recruited through Prolific and the survey created via Qualtrics.Compared to controls, participants viewing CBT DTCA videos (with or without information on antidepressants) were more willing to engage in CBT, had less public and self-stigma associated with CBT, and believed CBT has less potential for harm. Compared to the CBT group, the CBT+MED group reported greater concern about the risks of disclosing personal information in a therapy setting.These results extend previous findings by applying the DTCA marketing style to a specific diagnosis and type of therapy. Findings indicate that DTCA-style ads for CBT for MDD can be effective in reducing stigma and increasing treatment willingness. They further suggest that DTCA-style marketing of evidence-based psychotherapies can be efficacious when created for specific treatments and disorders. The findings have substantial implications for public health and the dissemination of evidence-based practice.
Show less
- Title
- Using population-level data to examine between-group health differences among transgender and cisgender United States military veterans
- Creator
- Woodward, Honor
- Date
- 2021
- Description
-
Some subgroups of military veterans, including those with marginalized identities, may be especially vulnerable to poor health. This...
Show moreSome subgroups of military veterans, including those with marginalized identities, may be especially vulnerable to poor health. This hypothesis is supported by the Minority Stress Theory framework, which posits that disparities in health can be attributed to the stress that minority individuals experience as a result of discrimination, prejudice, and oppression (Meyer, 1995; Meyer, 2003). A specific, potentially marginalized group of veterans that is under-explored regarding health is transgender veterans. Using data from the 2019 U.S. Behavioral Risk Factor Surveillance System (BRFSS), the current study hypothesized that transgender U.S. military veterans will report worse health than cisgender U.S. military veterans. Using case control matching, groups of transgender veterans (n = 124) and cisgender veterans (n = 104) were compared on several population-relevant health outcome measures. Chi-square tests of independence were conducted to test for significant differences between transgender and cisgender military veterans on the likelihood of experiencing certain health conditions, engaging in certain health behaviors, and utilizing health care services. Independent samples t-tests were used to test continuous health outcomes, such as self-reported mental health, physical health, and access to health care services. Gender identity was significantly associated with only one health outcome variable, with transgender veterans being more likely than cisgender veterans to have received a formal depression diagnosis (p = .01, phi = .17). No significant differences emerged between transgender and cisgender veterans on continuous health outcome variables. This suggests that previous literature on health disparities between transgender and cisgender individuals may not be generalizable to transgender veterans.
Show less